NCT04201457 2026-02-03A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF AberrationPediatric Brain Tumor ConsortiumPhase 1/2 Active not recruiting57 enrolled